These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9421092)

  • 1. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.
    Nakanishi Y; Kodama J; Yoshinouchi M; Tokumo K; Kamimura S; Okuda H; Kudo T
    Int J Gynecol Pathol; 1997 Jul; 16(3):256-62. PubMed ID: 9421092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor.
    Sönmezer M; Güngör M; Ensari A; Ortaç F
    Int J Gynecol Cancer; 2004; 14(1):82-8. PubMed ID: 14764033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
    Yamamoto S; Konishi I; Mandai M; Kuroda H; Komatsu T; Nanbu K; Sakahara H; Mori T
    Br J Cancer; 1997; 76(9):1221-7. PubMed ID: 9365173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
    Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
    Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors.
    Inan S; Vatansever S; Celik-Ozenci C; Sanci M; Dicle N; Demir R
    Histol Histopathol; 2006 Oct; 21(10):1055-64. PubMed ID: 16835828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF beta1 expression and angiogenesis in colorectal cancer tissue.
    Xiong B; Gong LL; Zhang F; Hu MB; Yuan HY
    World J Gastroenterol; 2002 Jun; 8(3):496-8. PubMed ID: 12046078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.
    Breier G; Blum S; Peli J; Groot M; Wild C; Risau W; Reichmann E
    Int J Cancer; 2002 Jan; 97(2):142-8. PubMed ID: 11774256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma.
    Nakayama K; Kanzaki A; Hata K; Katabuchi H; Okamura H; Miyazaki K; Fukumoto M; Takebayashi Y
    Cancer Lett; 2002 Feb; 176(2):215-23. PubMed ID: 11804750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Cancer; 1999 Oct; 86(8):1455-62. PubMed ID: 10526273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B; Reich R; Kopolovic J; Berner A; Nesland JM; Kristensen GB; Tropé CG; Bryne M; Risberg B; van de Putte G; Goldberg I
    Clin Exp Metastasis; 2002; 19(2):135-44. PubMed ID: 11964077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer.
    Seki N; Kodama J; Hongo A; Miyagi Y; Yoshinouchi M; Kudo T
    Eur J Cancer; 2000 Jan; 36(1):68-73. PubMed ID: 10741297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF beta-1 regulation of VEGF production by breast cancer cells.
    Donovan D; Harmey JH; Toomey D; Osborne DH; Redmond HP; Bouchier-Hayes DJ
    Ann Surg Oncol; 1997 Dec; 4(8):621-7. PubMed ID: 9416408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma.
    Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
    Cancer; 1998 Dec; 83(12):2528-33. PubMed ID: 9874459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
    Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
    Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor.
    Callagy G; Dimitriadis E; Harmey J; Bouchier-Hayes D; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):104-9. PubMed ID: 10937057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
    Ciardiello F; Caputo R; Bianco R; Damiano V; Fontanini G; Cuccato S; De Placido S; Bianco AR; Tortora G
    Clin Cancer Res; 2001 May; 7(5):1459-65. PubMed ID: 11350918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression.
    Inoue K; Ozeki Y; Suganuma T; Sugiura Y; Tanaka S
    Cancer; 1997 Jan; 79(2):206-13. PubMed ID: 9010092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological analysis of angiogenic factors in renal cell carcinoma.
    Yagasaki H; Kawata N; Takimoto Y; Nemoto N
    Int J Urol; 2003 Apr; 10(4):220-7. PubMed ID: 12657102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression in early stage ovarian carcinoma.
    Paley PJ; Staskus KA; Gebhard K; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
    Cancer; 1997 Jul; 80(1):98-106. PubMed ID: 9210714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.